INSMED Inc — Director's Dealing 2025

Apr 3, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-04-01

Reporting Person: Lewis William (Director, Chair and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-04-01	Common Stock	M	6830	$10.85	Acquired	240754	Indirect
2025-04-01	Common Stock	S	3021	$72.29	Disposed	237733	Indirect
2025-04-01	Common Stock	S	772	$73.44	Disposed	236961	Indirect
2025-04-01	Common Stock	S	2232	$74.78	Disposed	234729	Indirect
2025-04-01	Common Stock	S	805	$75.26	Disposed	233924	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-04-01	Stock Option (right to buy)	$10.85	M	6830	Disposed	2026-05-19	Common Stock (6830)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	334186	Direct
Common Stock	50500	Indirect

Footnotes

F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2: This is the weighted average sales price representing 3,021 shares sold at prices ranging from $72.00 to $72.88 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F3: This is the weighted average sales price representing 772 shares sold at prices ranging from $73.04 to $73.77 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F4: This is the weighted average sales price representing 2,232 shares sold at prices ranging from $74.10 to $75.09 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F5: This is the weighted average sales price representing 805 shares sold at prices ranging from $75.10 to $75.46 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F6: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.